XML 23 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common stock
Additional paid-in capital
Additional paid-in capital
Cumulative Effect, Period of Adoption, Adjustment
Retained earnings
Retained earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2020     44,346,630          
Beginning balance at Dec. 31, 2020 $ 1,211,018   $ 443 $ 456,274   $ 809,107   $ (54,806)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 136,209         136,209    
Other comprehensive loss, net of tax expense (16,383)             (16,383)
Exercise of stock options (in shares)     68,601          
Exercise of stock options 2,880   $ 1 2,879        
Issuance of shares under employee stock purchase plan (in shares)     58,145          
Issuance of shares under employee stock purchase plan 4,232   $ 1 4,231        
Redemption of 3.25% Convertible Note including tax impact (in shares)     3,050,850          
Redemption of 3.25% Convertible Note including tax impact 44,222   $ 31 44,191        
Issuance of/ vested restricted stock, net (in shares)     546,684          
Issuance of/ vested restricted stock, net 0   $ 5 (5)        
Repurchase and retirement of common stock (in shares)     (245,083)          
Repurchase and retirement of common stock (29,855)   $ (3) (15,825)   (14,027)    
Share-based compensation 19,119     19,119        
Other, net (2,183)     (2,371)   188    
Ending balance (in shares) at Sep. 30, 2021     47,825,827          
Ending balance at Sep. 30, 2021 1,369,259   $ 478 508,493   931,477   (71,189)
Beginning balance (in shares) at Jun. 30, 2021     44,708,235          
Beginning balance at Jun. 30, 2021 1,294,500   $ 447 461,422   892,605   (59,974)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 42,569         42,569    
Other comprehensive loss, net of tax expense (11,215)             (11,215)
Exercise of stock options (in shares)     23,250          
Exercise of stock options 1,549     1,549        
Redemption of 3.25% Convertible Note including tax impact (in shares)     3,031,817          
Redemption of 3.25% Convertible Note including tax impact 44,223   $ 31 44,192        
Issuance of/ vested restricted stock, net (in shares)     112,166          
Issuance of/ vested restricted stock, net 0   $ 1 (1)        
Repurchase and retirement of common stock (in shares)     (49,641)          
Repurchase and retirement of common stock (6,921)   $ (1) (3,035)   (3,885)    
Share-based compensation 6,755     6,755        
Other, net (2,201)     (2,389)   188    
Ending balance (in shares) at Sep. 30, 2021     47,825,827          
Ending balance at Sep. 30, 2021 $ 1,369,259   $ 478 508,493   931,477   (71,189)
Beginning balance (in shares) at Dec. 31, 2021 47,440,137   47,440,137          
Beginning balance at Dec. 31, 2021 $ 1,967,732 $ (64,701) $ 474 509,122 $ (88,137) 1,515,358 $ 23,436 (57,222)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) (3,714)         (3,714)    
Other comprehensive loss, net of tax expense (51,396)             (51,396)
Exercise of stock options (in shares)     5,439          
Exercise of stock options 148     148        
Issuance of shares under employee stock purchase plan (in shares)     76,741          
Issuance of shares under employee stock purchase plan 5,235   $ 1 5,234        
Issuance of/ vested restricted stock, net (in shares)     456,963          
Issuance of/ vested restricted stock, net 0   $ 4 (4)        
Repurchase and retirement of common stock (in shares)     (789,373)          
Repurchase and retirement of common stock (76,545)   $ (7) (14,881)   (61,657)    
Share-based compensation 20,806     20,806        
Other, net $ (3,920)     (16)   (3,904)    
Ending balance (in shares) at Sep. 30, 2022 47,189,907   47,189,907          
Ending balance at Sep. 30, 2022 $ 1,793,645   $ 472 432,272   1,469,519   (108,618)
Beginning balance (in shares) at Jun. 30, 2022     47,191,337          
Beginning balance at Jun. 30, 2022 1,794,196   $ 472 426,104   1,451,316   (83,696)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net income (loss) 18,185         18,185    
Other comprehensive loss, net of tax expense (24,922)             (24,922)
Issuance of/ vested restricted stock, net (in shares)     1,171          
Repurchase and retirement of common stock (in shares)     (2,601)          
Repurchase and retirement of common stock (200)     (218)   18    
Share-based compensation $ 6,386     6,386        
Ending balance (in shares) at Sep. 30, 2022 47,189,907   47,189,907          
Ending balance at Sep. 30, 2022 $ 1,793,645   $ 472 $ 432,272   $ 1,469,519   $ (108,618)